Recombinant TNFRSF8 (Brentuximab Biosimilar) anticorps

N° du produit ABIN6964430

Détail du produit anti-TNFRSF8 (Brentuximab Biosimilar) anticorps

Antigène: TNFRSF8 (Brentuximab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Chimeric

Conjugué: Cet anticorp TNFRSF8 (Brentuximab Biosimilar) est non-conjugé

Application: ELISA

Fonction: Anti-CD30 (brentuximab biosimilar) mAb

Attributs du produit: Common Name: SGN-35, cAC10-Val-Cit-MMAE

Purification: Purified from cell culture supernatant by affinity chromatography

Classe de qualité: Research Grade

Isotype: IgG1

Information d'application

Indications d'application: ELISA 1:5000-10000

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: 50 % Glycerol, PBS, pH 7.4, 0.1 % BSA, 0.1 % Procline 300

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur TNFRSF8 (Brentuximab Biosimilar)

Antigène: TNFRSF8 (Brentuximab Biosimilar)

Autre désignation: CD30 (Brentuximab Biosimilar) (TNFRSF8 (Brentuximab Biosimilar) Produits)

Classe de substances: Biosimilar

Sujet: Synonyms: TNFRSF8,CD30,D1S166E,Ki-1